ST遊久(600652.SH)收到參股公司北京信託紅利款2233.52萬元
格隆匯 12 月 30日丨ST遊久(600652.SH)公佈,公司參股的北京國際信託有限公司(“北京信託”)股東會審議通過的2019年度利潤分配方案為:以北京信託2019年末總持股份額22億股為基數,按0.16元/股向全體股東派發現金紅利。2019年末,公司持有的北京信託股份份額為約1.4億股,佔其總持股份額的6.3452%,故此次可獲得紅利款約2233.52萬元。基於前述北京信託股東會決議,根據《企業會計準則》的相關規定,公司已將上述紅利款計入本年度投資收益。
2020年12月30日,公司已收到上述紅利款,此次收到應收股利對公司損益不再另外產生影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.